Stock Analiz

agilon health, inc. (AGL) financials: revenue, earnings and cash flow

Fiscal 2019–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

agilon health, inc.’s revenue went from $794M in fiscal 2019 to $5.9B in fiscal 2025, growth of about 39.8% a year.

Net income in fiscal 2025 was -$391M, a net margin of -6.6%; the best year in this period was 2020 with -$60M.

Over the twelve months to September 30, 2026, revenue was $6.0B and net income -$87M.

Free cash flow was -$119M in fiscal 2025 and positive in 0 of the 7 years shown.

The diluted share count rose 40% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2019: $794M20192020: $1.2B20202021: $1.5B20212022: $2.4B20222023: $4.3B20232024: $6.1B20242025: $5.9B2025$5.9B
Net income
2019: -$283M20192020: -$60M20202021: -$406M20212022: -$107M20222023: -$263M20232024: -$260M20242025: -$391M2025-$391M
Free cash flow
2019: -$107M20192020: -$55M20202021: -$155M20212022: -$146M20222023: -$172M20232024: -$71M20242025: -$119M2025-$119M
EPS (diluted)
2019: $-23.9720192020: $-5.0020202021: $-25.7520212022: $-5.5020222023: $-12.0020232024: $-15.2520242025: $-24.502025$-24.50

Income statement

Fiscal yearTTM2025202420232022202120202019
Revenue$6.0B$5.9B$6.1B$4.3B$2.4B$1.5B$1.2B$794M
Gross profit————————
Operating income-$154M-$463M-$292M-$232M-$105M-$372M-$57M-$107M
Net income-$87M-$391M-$260M-$263M-$107M-$406M-$60M-$283M
EPS (diluted)$-6.69$-24.50$-15.25$-12.00$-5.50$-25.75$-5.00$-23.97
R&D————————
Revenue growth—−2.1%+40.4%+80.7%+57.0%+24.9%+53.4%—

Cash flow

Fiscal yearTTM2025202420232022202120202019
Operating cash flow-$4M-$106M-$58M-$156M-$131M-$148M-$53M-$104M
Capital spending-$13M-$13M-$13M-$16M-$15M-$7M-$2M-$3M
Free cash flow-$17M-$119M-$71M-$172M-$146M-$155M-$55M-$107M
Dividends paid—$0$0$0$0$0$0$0
Buybacks—$0$0$200M$0$0$7M$0
Stock-based pay$58M$49M$51M$69M$28M$292M$7M$5M

Balance sheet

Fiscal yearTTM2025202420232022202120202019
Cash—$174M$188M$108M$877M$1.0B$107M$139M
Debt—$37M$44M$52M$56M$60M$77M—
Equity—$127M$471M$662M$1.0B$1.1B-$285M-$232M
Total assets—$1.3B$1.7B$1.7B$1.7B$1.6B$446M—
Shares (diluted)17M17M16M16M16M15M13M12M

Margins and returns

Fiscal yearTTM2025202420232022202120202019
Gross margin————————
Operating margin-2.6%-7.8%-4.8%-5.4%-4.4%-24.5%-4.7%-13.4%
Net margin-1.5%-6.6%-4.3%-6.1%-4.5%-26.7%-4.9%-35.6%
FCF margin-0.3%-2.0%-1.2%-4.0%-6.1%-10.2%-4.5%-13.4%
ROIC—-223.8%-44.8%-25.7%-7.6%-25.5%——
ROE—-308.8%-55.2%-39.7%-10.2%-37.2%21.1%121.8%

Frequently asked questions

What is agilon health, inc.’s annual revenue?

$5.9B in fiscal 2025 and $6.0B over the twelve months to September 30, 2026.

How much profit does agilon health, inc. make?

Net income was -$391M in fiscal 2025 (net margin -6.6%).

Is agilon health, inc.’s revenue growing?

No: revenue fell 2.1% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.